Displaying 85 - 96 of 104
Immune-Mediated and Cholestatic Diseases

Challenges in the Management of Patients with Cholestatic Liver Diseases

Webcasts
View
Metabolism, Alcohol & Toxicity

The NASH care pathway: Drivers and emerging trends

Webcasts
View
Metabolism, Alcohol & Toxicity

How to optimise NASH patient care? – Collaboration with different specialities

Webcasts
View
Metabolism, Alcohol & Toxicity

How do non-invasive techniques improve patient identification and risk stratification?

Webcasts
View
Metabolism, Alcohol & Toxicity

Future improvements needed for care pathways for patients with NASH – Q&A

Webcasts
View
General Hepatology

Chair’s welcome

Webcasts
View
General Hepatology

New insights into the role of FXR agonism in PBC

Webcasts
View
General Hepatology

Obethicolic Acid in the real world: what have we learned so far? Experience from Spain and Portugal

Webcasts
View
General Hepatology

Obethicolic Acid in the real world: what have we learned so far? Experience from Italy

Webcasts
View
General Hepatology

Obethicolic Acid in the real world: what have we learned so far? Experience from UK

Webcasts
View
General Hepatology

Q&A

Webcasts
View
Viral Hepatitis

Opening address: Creating possible

Webcasts
View
Displaying 85 - 96 of 104